2008•Pharmacology Biochemistry and BehaviorOpen access

Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113

Kelly S. Sink, Kiran Vemuri, JodiAnne T. Wood, Alexandros Makriyannis, John D. Salamone

Open full text 44 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 44 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: AM251, Rimonabant, Cannabinoid receptor, Antagonist, Cannabinoid, Pharmacology, Bioavailability, Oral administration

Back to paper search Browse research topics Original source

Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113 — Research Paper | ScholarLens